Developer docs
API playgroundTry for free, no card

Search company profiles

karex

Full company profile

uuid003gdz7

Namestring
karex
Legal namestring
Karex Berhad (1018579-U)
Websiteurl
karex.com.my
Company typeenum
Public
Founded yearint
1988
Descriptiontext

Karex Berhad is the world's largest condom manufacturer, producing over 5 billion condoms annually — approximately one-fifth of global supply — across four manufacturing facilities in Malaysia (Port Klang, Pontian, Senai) and Thailand (Hat Yai), supported by a 2,980-person workforce. The company operates three distinct go-to-market motions: OEM contract manufacturing for global consumer brands including Durex and Trojan; direct-to-consumer sales of owned brands (ONE, MyONE, Carex, Pasante, Trustex, Atlas, Adore) through e-commerce and retail channels; and B2B supply to government health systems (NHS UK) and humanitarian organizations (UN aid programs). Manufacturing capabilities span latex and nitrile condom production, electronic testing for quality assurance, and adjacent medical products including personal lubricants, probe covers, Foley balloon catheters, and medical gloves. International sales offices in Boston (Global Protection Corp.) and Brighton (Pasante Healthcare) provide regional distribution depth across 130+ countries.

The company is publicly listed on Bursa Malaysia (KLSE:KAREX) since 2013 and headquartered in Port Klang, Selangor. Revenue is generated through quote-based B2B contracts with major brand clients, public-sector tenders, and distributed consumer product sales. The business model combines high-volume manufacturing scale with a diversified brand portfolio, cushioned by ESG positioning (FTSE4Good 4.5/5 rating, top 1% globally) and regulatory compliance (ISO 4074, ISO 14001, ISO 45001). Proprietary nitrile condom technology, custom-fit sizing under the MyONE brand, and ongoing R&D in dipping process innovation provide limited product differentiation within a commodity-adjacent category. Recent operating pressures include 20–30% announced price increases in April 2026 to offset raw material inflation (silicone oil +30%, nitrile latex +100%, natural rubber +33%) linked to Iran-war-related supply chain disruptions, against a backdrop of 30% demand surge driven by USAID funding contraction.

Short descriptiontext

Karex Berhad is the world's largest condom manufacturer, producing over 5 billion units annually (one-fifth of global supply) from four facilities in Malaysia and Thailand. It serves global consumer brands (Durex, Trojan) via OEM, sells owned brands directly to consumers, and supplies NHS and UN health programs across 130+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersPort Klang, Malaysia
HQ citystring
Port Klang
HQ countrystring
Malaysia
HQ regionstring
Asia
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
condom manufacturing, personal lubricants, medical devices, OEM manufacturing, sexual wellness products
Industry2 codes
PRIMARYCRAFACAM
Sexual Wellness & Intimacy Products DTC
Consumer Products & Retail/E-commerce & Marketplaces/Direct-to-Consumer (DTC) Brand E-commerce
SECONDARYCRADALAJ
Protective Disposable Wear (Masks, Gloves, Shoe Covers, Hairnets)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Paper Goods & Disposables (Tissue, Diapers, Feminine Care)
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Plastics and Rubber Products Manufacturing326
SIC code1 code
  • Plastic Materials, Synth Resins & Nonvulcan Elastomers2821
Product category
Condom Manufacturing
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1OEM/Contract Manufacturing
TypeOne Time License
Description

Manufacturing condoms for major global brands including Durex and Trojan under contract manufacturing arrangements. Represents core B2B revenue stream with established client relationships.

livemint.com
2Own Brand Portfolio Sales
TypeTransaction Fee
Description

Direct sales of proprietary brands including ONE, MyONE, Carex, Pasante, Trustex, Atlas, Adore through e-commerce and retail channels. Includes B2C sales to end consumers.

businesstoday.in
3Healthcare System Supply
TypeOne Time License
Description

Supply contracts with government health systems including NHS UK, UN aid programs, and public health organizations for HIV prevention and reproductive health initiatives.

theguardian.com
4Diverse Healthcare Products
TypeOne Time License
Description

Manufacturing and sales of complementary products including personal lubricants, probe covers, Foley balloon catheters, and medical gloves.

karex.com.my
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1Price increase announcement due to supply chain disruptions
ModelUnit PricingBilling cadencePay-as-you-go
Notes

20-30% price increase announced in April 2026, with further increases possible if Iran conflict disruptions persist. Silicone oil prices rose approximately 30%, nitrile latex prices doubled, and natural rubber prices climbed a third since January 2026.

cbsnews.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 13 records shown
1ONE
Description

Condom brand operating in US, Malaysia, Singapore, Vietnam, Indonesia, and Thailand markets

karex.com.my
+12 more records
Core offering1 text field

Karex is the world's largest condom manufacturer, producing over 5 billion condoms per year across facilities in Malaysia and Thailand, supplying roughly one-fifth of global demand. The company makes male and female condoms, personal lubricants, probe covers, Foley balloon catheters, and gloves through both contract manufacturing for international brands (e.g., Durex, Trojan) and its own consumer brands (ONE, MyONE, Carex, Pasante, Trustex).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over 5 billion condoms produced annually - one-fifth of global supply
+3 more records
Product overview1 text field

Karex operates as the world's largest condom manufacturer with a diversified portfolio of sexual wellness and healthcare products. The company produces male latex and nitrile condoms (their core product representing one-fifth of global supply at 5+ billion units annually), personal lubricants, probe covers, foley balloon catheters, and gloves. Products are marketed through multiple brand tiers: owned brands including ONE, MyONE, and Carex; and acquired brands including Pasante (UK), Trustex (US), and Atlas. The company operates globally through subsidiaries Global Protection Corp. (Boston, North/South America) and Pasante Healthcare (Brighton, Europe/Middle East), while manufacturing is centralized in Malaysia and Thailand facilities.

Product and service6 records
1Male condoms
CategoryCondoms
Description

Male condoms (latex and non-latex including proprietary nitrile) manufactured at scale for OEM customers such as Durex and Trojan and for the company's own consumer brands (ONE, MyONE, Carex, Pasante, Trustex).

2Female condoms
CategoryCondoms
Description

Female condoms manufactured for global brand owners and public-health programs.

3Personal lubricants
CategoryPersonal care
Description

Personal lubricant products sold under Karex's owned brands and supplied to OEM customers, complementing its condom portfolio.

4Probe covers
CategoryMedical devices
Description

Latex probe covers used in medical/ultrasound applications, manufactured using the company's dipping-process know-how.

5Foley balloon catheters
CategoryMedical devices
Description

Foley balloon catheters produced for healthcare customers, leveraging existing latex manufacturing expertise.

6Examination gloves
CategoryMedical devices
Description

Examination gloves manufactured as part of the company's adjacent medical-products portfolio, primarily latex-based.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-02
Description

15-year power purchase agreement to install a 2.2-MWp solar photovoltaic system at Karex's Innolatex Thailand Limited facility in Hat Yai city. Expected to generate approximately 44 GWh of green electricity annually, reducing carbon emissions by 26,000 tonnes and supporting Thailand's renewable energy targets.

2Ministry of Health Malaysia
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Partnership through the DHSKP (Differentiated HIV Services for Key Populations) Programme, distributing 700,000 condoms and 700,000 lubricants worth RM2.3 million in 2025. Products reach 50,000+ individuals through 200+ trained community healthcare workers at 52 outreach sites.

karex.com.my
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Collaboration on DHSKP programme distributing 1.4 million protection units in 2025. Also supports art against AIDS (AAA) initiative which has raised over RM2 million since 2016 for HIV/AIDS programmes. MAF coordinates distribution through community organizations.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2024-01-01
Description

Partnership to distribute 12,000+ awareness packs across Hilton properties in Malaysia including Kuala Lumpur, Kota Kinabalu, Kuching, and nine other locations, promoting HIV prevention and safe practices to hotel guests and employees.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Partnership to convert obsolete foil rolls into alternative fuel through Lafarge Malaysia cement kilns, replacing fossil fuels and reducing carbon emissions. Supports Karex's sustainable packaging and circular economy initiatives.

6Malaysian Rubber Council (MRC)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Collaboration on MRC Scholarship Awards for Undergraduate Studies, supporting young Malaysians pursuing education in rubber industry fields. Strengthens future talent pipeline for Malaysia's rubber manufacturing sector.

karex.com.my
7Fair Rubber Association
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2019-05-01
Description

Membership supporting fair trade practices and improving livelihoods of natural latex producers. Strengthens responsible sourcing and ethical supply chain practices across Karex's rubber supply chain.

karex.com.my
8art against AIDS (AAA)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2016-01-01
Description

Youth-led advocacy initiative using art to challenge HIV/AIDS stigma. Raised over RM2 million for Malaysian AIDS Foundation through collaborations with higher institutions, community clinics, government agencies, NGOs, and corporate partners. Annual exhibition showcases creative works supporting HIV prevention.

karex.com.my
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2016-01-01
Description

Community health organization partner for HIV prevention programs. Residents from Rumah Inap PT Foundation participate in packing and distributing Sexual Transmission Prevention Kits, creating livelihood opportunities alongside health education.

Recent move13 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Japanese manufacturer of condoms and other rubber-based consumer products (including gloves). Okamoto is a direct category competitor with both OEM and branded condom offerings across Asia, and is comparable in latex/rubber manufacturing expertise and global brand reach.

TypeBroad incumbent
Description

Reckitt owns the Durex brand — Karex's largest disclosed OEM customer. While Reckitt is a diversified consumer health conglomerate (not a pure-play condom manufacturer), it is the most strategically relevant counterparty for Karex and represents both a major revenue dependency and a comparable category leader in sexual wellness.

TypeDirect peer
Description

Japanese condom manufacturer specializing in polyurethane (non-latex) condoms as well as traditional latex. Sagami is comparable to Karex as a specialist condom manufacturer with proprietary non-latex technology, providing a relevant competitor in the premium and latex-allergy segments.

TypeBroad incumbent
Description

Church & Dwight owns the Trojan brand, the leading condom brand in the US and another of Karex's major OEM customers. Like Reckitt, it is a diversified consumer products company where condoms are a category within a broader household products portfolio, but it is a direct customer and brand owner in the same sexual wellness category.

5Thai Nippon Rubber Industry (TNRI)
TypeDirect peer
Description

Thailand-based condom manufacturer producing male latex condoms for global OEM clients. TNRI is a directly comparable regional manufacturing peer operating in the same Asian production corridor and serving the same global condom OEM customer base.

TypeEmerging player
Description

Indian pharmaceutical company that has entered condom manufacturing and was cited in the data as a competitor also warning of condom price increases due to similar supply chain disruptions. It represents a low-cost Asian competitor that could pressure Karex's OEM economics, especially in cost-sensitive markets.

7HLL Lifecare
TypeDirect peer
Description

Indian government-owned condom and contraceptive manufacturer supplying public health programs and tenders. HLL is a direct peer to Karex in OEM-style condom manufacturing for institutional/government buyers (analogous to NHS/UN supply) and competes in the same humanitarian-aid supply ecosystem.

TypeEmerging player
Description

Swedish sexual wellness brand and condom manufacturer with strong European presence. RFSU is comparable to Karex's owned-brand strategy (ONE, Pasante) as a branded sexual wellness player rather than a pure OEM, and competes for the same European premium-segment consumer.

9Convex Latex
TypeRegional player
Description

Indian condom manufacturer focused on domestic and emerging-market supply. Convex is a regional manufacturing peer competing in similar price-sensitive OEM and public-health tender markets, though it does not directly overlap with Karex's primary North American/European customer base.

TypeDirect peer
Description

Indian condom manufacturer producing male condoms for branded and OEM customers globally. Cupid is a direct peer in contract manufacturing scale, latex condom technology, and participation in UN/tender supply programs, and represents an alternative low-cost source for global condom buyers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance10 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

karex

Condom Manufacturingkarex.com.my

Karex Berhad is the world's largest condom manufacturer, producing over 5 billion units annually (one-fifth of global supply) from four facilities in Malaysia and Thailand. It serves global consumer brands (Durex, Trojan) via OEM, sells owned brands directly to consumers, and supplies NHS and UN health programs across 130+ countries.

What karex does

Karex Berhad is the world's largest condom manufacturer, producing over 5 billion condoms annually — approximately one-fifth of global supply — across four manufacturing facilities in Malaysia (Port Klang, Pontian, Senai) and Thailand (Hat Yai), supported by a 2,980-person workforce. The company operates three distinct go-to-market motions: OEM contract manufacturing for global consumer brands including Durex and Trojan; direct-to-consumer sales of owned brands (ONE, MyONE, Carex, Pasante, Trustex, Atlas, Adore) through e-commerce and retail channels; and B2B supply to government health systems (NHS UK) and humanitarian organizations (UN aid programs). Manufacturing capabilities span latex and nitrile condom production, electronic testing for quality assurance, and adjacent medical products including personal lubricants, probe covers, Foley balloon catheters, and medical gloves. International sales offices in Boston (Global Protection Corp.) and Brighton (Pasante Healthcare) provide regional distribution depth across 130+ countries.

The company is publicly listed on Bursa Malaysia (KLSE:KAREX) since 2013 and headquartered in Port Klang, Selangor. Revenue is generated through quote-based B2B contracts with major brand clients, public-sector tenders, and distributed consumer product sales. The business model combines high-volume manufacturing scale with a diversified brand portfolio, cushioned by ESG positioning (FTSE4Good 4.5/5 rating, top 1% globally) and regulatory compliance (ISO 4074, ISO 14001, ISO 45001). Proprietary nitrile condom technology, custom-fit sizing under the MyONE brand, and ongoing R&D in dipping process innovation provide limited product differentiation within a commodity-adjacent category. Recent operating pressures include 20–30% announced price increases in April 2026 to offset raw material inflation (silicone oil +30%, nitrile latex +100%, natural rubber +33%) linked to Iran-war-related supply chain disruptions, against a backdrop of 30% demand surge driven by USAID funding contraction.

karex firmographics

Firmographics
Name
karex
Legal name
Karex Berhad (1018579-U)
Website
https://karex.com.my
Company type
Public
Founded year
1988
Operating status
Operating
Headcount range
251–500 employees
Short description
Karex Berhad is the world's largest condom manufacturer, producing over 5 billion units annually (one-fifth of global supply) from four facilities in Malaysia and Thailand. It serves global consumer brands (Durex, Trojan) via OEM, sells owned brands directly to consumers, and supplies NHS and UN health programs across 130+ countries.
Ownership category
akta.pro rank

karex industry classification

Industry
Product category
Condom Manufacturing
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Plastics and Rubber Products Manufacturing (326)
SIC
Plastic Materials, Synth Resins & Nonvulcan Elastomers (2821)
akta.pro industry
PRIMARYCRAFACAM
Sexual Wellness & Intimacy Products DTC
Consumer Products & Retail/E-commerce & Marketplaces/Direct-to-Consumer (DTC) Brand E-commerce
SECONDARYCRADALAJ
Protective Disposable Wear (Masks, Gloves, Shoe Covers, Hairnets)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Paper Goods & Disposables (Tissue, Diapers, Feminine Care)

Keywords

  • Condom manufacturing
  • Personal lubricants
  • Medical devices
  • OEM manufacturing
  • Sexual wellness products

Where karex is headquartered

Location

Headquarters

HQ city
Port Klang
HQ country
Malaysia
HQ region
Asia

Offices6 records

Markets served

karex business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. OEM/Contract Manufacturing: Manufacturing condoms for major global brands including Durex and Trojan under contract manufacturing arrangements. Represents core B2B revenue stream with established client relationships.
  2. Own Brand Portfolio Sales: Direct sales of proprietary brands including ONE, MyONE, Carex, Pasante, Trustex, Atlas, Adore through e-commerce and retail channels. Includes B2C sales to end consumers.
  3. Healthcare System Supply: Supply contracts with government health systems including NHS UK, UN aid programs, and public health organizations for HIV prevention and reproductive health initiatives.
  4. Diverse Healthcare Products: Manufacturing and sales of complementary products including personal lubricants, probe covers, Foley balloon catheters, and medical gloves.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goPrice increase announcement due to supply chain disruptions

Go-to-market motion2 records

Distribution channels6 records

Marketing channels5 records

karex product offering

Product offering

Core offering

Karex is the world's largest condom manufacturer, producing over 5 billion condoms per year across facilities in Malaysia and Thailand, supplying roughly one-fifth of global demand. The company makes male and female condoms, personal lubricants, probe covers, Foley balloon catheters, and gloves through both contract manufacturing for international brands (e.g., Durex, Trojan) and its own consumer brands (ONE, MyONE, Carex, Pasante, Trustex).

Product overview

Karex operates as the world's largest condom manufacturer with a diversified portfolio of sexual wellness and healthcare products. The company produces male latex and nitrile condoms (their core product representing one-fifth of global supply at 5+ billion units annually), personal lubricants, probe covers, foley balloon catheters, and gloves. Products are marketed through multiple brand tiers: owned brands including ONE, MyONE, and Carex; and acquired brands including Pasante (UK), Trustex (US), and Atlas. The company operates globally through subsidiaries Global Protection Corp. (Boston, North/South America) and Pasante Healthcare (Brighton, Europe/Middle East), while manufacturing is centralized in Malaysia and Thailand facilities.

Differentiator

Problem solved

Functional benefit

Brands

  • ONE: Condom brand operating in US, Malaysia, Singapore, Vietnam, Indonesia, and Thailand markets
  • MyONE
  • Carex
  • Pasante
  • Trustex
  • Inno
  • Esp
  • Fantasy
  • Adore
  • Atlas
  • Uro
  • Urocare
  • Revoc

Products and services

  • Male condoms Male condoms (latex and non-latex including proprietary nitrile) manufactured at scale for OEM customers such as Durex and Trojan and for the company's own consumer brands (ONE, MyONE, Carex, Pasante, Trustex).
  • Female condoms Female condoms manufactured for global brand owners and public-health programs.
  • Personal lubricants Personal lubricant products sold under Karex's owned brands and supplied to OEM customers, complementing its condom portfolio.
  • Probe covers Latex probe covers used in medical/ultrasound applications, manufactured using the company's dipping-process know-how.
  • Foley balloon catheters Foley balloon catheters produced for healthcare customers, leveraging existing latex manufacturing expertise.
  • Examination gloves Examination gloves manufactured as part of the company's adjacent medical-products portfolio, primarily latex-based.

Quantifiable outcome

  • Over 5 billion condoms produced annually - one-fifth of global supply
  • +3 more outcomes

Companies that use karex

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles2 records

karex technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

karex partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • Levanta RenewablescoreStrategic or Co-development Partner · 2 June 202515-year power purchase agreement to install a 2.2-MWp solar photovoltaic system at Karex's Innolatex Thailand Limited facility in Hat Yai city. Expected to generate approximately 44 GWh of green electricity annually, reducing carbon emissions by 26,000 tonnes and supporting Thailand's renewable energy targets.
  • Ministry of Health MalaysiacoreStrategic or Co-development Partner · 1 January 2025Partnership through the DHSKP (Differentiated HIV Services for Key Populations) Programme, distributing 700,000 condoms and 700,000 lubricants worth RM2.3 million in 2025. Products reach 50,000+ individuals through 200+ trained community healthcare workers at 52 outreach sites.
  • Malaysian AIDS Foundation (MAF)coreStrategic or Co-development Partner · 1 January 2025Collaboration on DHSKP programme distributing 1.4 million protection units in 2025. Also supports art against AIDS (AAA) initiative which has raised over RM2 million since 2016 for HIV/AIDS programmes. MAF coordinates distribution through community organizations.
  • Hilton Hotels MalaysiaminorGTM or Marketing Partner · 1 January 2024Partnership to distribute 12,000+ awareness packs across Hilton properties in Malaysia including Kuala Lumpur, Kota Kinabalu, Kuching, and nine other locations, promoting HIV prevention and safe practices to hotel guests and employees.
  • OCK RecycleminorStrategic or Co-development Partner · 1 January 2023Partnership to convert obsolete foil rolls into alternative fuel through Lafarge Malaysia cement kilns, replacing fossil fuels and reducing carbon emissions. Supports Karex's sustainable packaging and circular economy initiatives.
  • Malaysian Rubber Council (MRC)minorStrategic or Co-development Partner · 1 January 2023Collaboration on MRC Scholarship Awards for Undergraduate Studies, supporting young Malaysians pursuing education in rubber industry fields. Strengthens future talent pipeline for Malaysia's rubber manufacturing sector.
  • Fair Rubber AssociationminorStrategic or Co-development Partner · 1 May 2019Membership supporting fair trade practices and improving livelihoods of natural latex producers. Strengthens responsible sourcing and ethical supply chain practices across Karex's rubber supply chain.
  • art against AIDS (AAA)coreStrategic or Co-development Partner · 1 January 2016Youth-led advocacy initiative using art to challenge HIV/AIDS stigma. Raised over RM2 million for Malaysian AIDS Foundation through collaborations with higher institutions, community clinics, government agencies, NGOs, and corporate partners. Annual exhibition showcases creative works supporting HIV prevention.
  • PT FoundationminorStrategic or Co-development Partner · 1 January 2016Community health organization partner for HIV prevention programs. Residents from Rumah Inap PT Foundation participate in packing and distributing Sexual Transmission Prevention Kits, creating livelihood opportunities alongside health education.

Scale indicators8 records

Recent moves13 records

Expansion highlights7 records

karex competitors and assessment

Company assessment

Broad incumbents

  • Okamoto Industries: Japanese manufacturer of condoms and other rubber-based consumer products (including gloves). Okamoto is a direct category competitor with both OEM and branded condom offerings across Asia, and is comparable in latex/rubber manufacturing expertise and global brand reach.
  • Reckitt Benckiser (Durex): Reckitt owns the Durex brand — Karex's largest disclosed OEM customer. While Reckitt is a diversified consumer health conglomerate (not a pure-play condom manufacturer), it is the most strategically relevant counterparty for Karex and represents both a major revenue dependency and a comparable category leader in sexual wellness.
  • Church & Dwight (Trojan): Church & Dwight owns the Trojan brand, the leading condom brand in the US and another of Karex's major OEM customers. Like Reckitt, it is a diversified consumer products company where condoms are a category within a broader household products portfolio, but it is a direct customer and brand owner in the same sexual wellness category.

Direct peers

  • Sagami Rubber Industries: Japanese condom manufacturer specializing in polyurethane (non-latex) condoms as well as traditional latex. Sagami is comparable to Karex as a specialist condom manufacturer with proprietary non-latex technology, providing a relevant competitor in the premium and latex-allergy segments.
  • Thai Nippon Rubber Industry (TNRI): Thailand-based condom manufacturer producing male latex condoms for global OEM clients. TNRI is a directly comparable regional manufacturing peer operating in the same Asian production corridor and serving the same global condom OEM customer base.
  • HLL Lifecare: Indian government-owned condom and contraceptive manufacturer supplying public health programs and tenders. HLL is a direct peer to Karex in OEM-style condom manufacturing for institutional/government buyers (analogous to NHS/UN supply) and competes in the same humanitarian-aid supply ecosystem.
  • Cupid Limited: Indian condom manufacturer producing male condoms for branded and OEM customers globally. Cupid is a direct peer in contract manufacturing scale, latex condom technology, and participation in UN/tender supply programs, and represents an alternative low-cost source for global condom buyers.

Emerging players

  • Mankind Pharma: Indian pharmaceutical company that has entered condom manufacturing and was cited in the data as a competitor also warning of condom price increases due to similar supply chain disruptions. It represents a low-cost Asian competitor that could pressure Karex's OEM economics, especially in cost-sensitive markets.
  • RFSU: Swedish sexual wellness brand and condom manufacturer with strong European presence. RFSU is comparable to Karex's owned-brand strategy (ONE, Pasante) as a branded sexual wellness player rather than a pure OEM, and competes for the same European premium-segment consumer.

Regional players

  • Convex Latex: Indian condom manufacturer focused on domestic and emerging-market supply. Convex is a regional manufacturing peer competing in similar price-sensitive OEM and public-health tender markets, though it does not directly overlap with Karex's primary North American/European customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

karex social profiles

Digital presence

karex compliance and trust

Trust signal

Compliance10 records

karex financial estimates

Financial estimate

Revenue estimate

Valuation estimate

karex leadership team

Management profile

Number of profiles

Profiles10 records

karex subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

karex funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

karex M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about karex

What does karex do?

Karex is the world's largest condom manufacturer, producing over 5 billion condoms per year across facilities in Malaysia and Thailand, supplying roughly one-fifth of global demand. The company makes male and female condoms, personal lubricants, probe covers, Foley balloon catheters, and gloves through both contract manufacturing for international brands (e.g., Durex, Trojan) and its own consumer brands (ONE, MyONE, Carex, Pasante, Trustex).

Is karex a public or private company?

karex is a public company. It is classified as public and is currently operating.

When was karex founded?

karex was founded in 1988. It employs 251 to 500 people.

Where is karex based?

karex is headquartered in Port Klang, Malaysia, in the Asia region.

How does karex make money?

Four revenue lines are on record. OEM/Contract Manufacturing is the primary driver. The others are own Brand Portfolio Sales, healthcare System Supply and diverse Healthcare Products.

Who are karex's main competitors?

Broad incumbents on record are Okamoto Industries, Reckitt Benckiser (Durex) and Church & Dwight (Trojan). Direct peers are Sagami Rubber Industries, Thai Nippon Rubber Industry (TNRI), HLL Lifecare and Cupid Limited. Emerging players are Mankind Pharma and RFSU. Convex Latex is listed as a regional player.

Does karex have an API?

No public API is recorded for karex.

What industry is karex in?

karex's product category is Condom Manufacturing. Its primary akta.pro industry code is CRAFACAM, Sexual Wellness & Intimacy Products DTC, with a secondary code of CRADALAJ, Protective Disposable Wear (Masks, Gloves, Shoe Covers, Hairnets). Its NAICS code is 339113 and its SIC code is 2821.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The future of tradingKarex Publishes 2026 Corporate Governance ReportKarex published its 2026 corporate governance report for the financial year ended June 30, 2026. The board has four independent non-executive directors, none serving more than nine years, and no strict tenure cap. A CEO-led Sustainability Working Committee oversees sustainability initiatives.The Edge MalaysiaKarex turns around in 4Q after US tariff refunds, flags cost pressures aheadKarex Bhd reported a net profit of RM3.79 million for the quarter ended June 30, 2026, up from a RM9.46 million loss, after US tariff refunds and price increases, though revenue fell 16% to RM101.17 million. The company expects continued cost pressures from geopolitical uncertainty, volatile exchange rates and higher raw material and logistics costs. A half-sen dividend was declared, payable Sept 11.YahooScott Galloway warns the Strait of Hormuz blockade could spiral into 'worldwide toll booths' — or something even worseNYU marketing professor Scott Galloway published an analysis arguing that the Strait of Hormuz blockade's second-order effects are being overlooked by markets fixated on oil prices. Multiple consumer product companies have announced price increases in response to supply chain disruptions, including condom maker Karex raising prices up to 30% and chemical giant Dow doubling its polyethylene price hike. A looming helium shortage has also emerged after Qatar's Ras Laffan complex, which produces roughly one-third of the world's commercial helium, was attacked early in the Iran conflict, with about 200 helium containers stranded in the Middle East.Fortune IndiaWest Asia tensions cloud outlook for personal care brands, margins under pressureWest Asia geopolitical tensions are intensifying cost pressures on India's personal care sector, with raw material costs rising 20–30% due to packaging and ingredient price hikes including polypropylene and specialised inputs like silicone oil and ammonia. Hindustan Unilever has announced 2–5% price increases citing anticipated 8–10% input cost inflation, while Malaysia-based Karex, the world's largest condom manufacturer supplying Durex and Trojan, indicated potential price hikes of 30% or more as production costs surge. Companies are responding with inventory buffers, supplier diversification, and localisation strategies, and are likely to delay new product launches to protect margins.Fortune IndiaWest Asia tensions cloud outlook for personal care brands, margins under pressureGeopolitical tensions in West Asia are driving crude oil and petrochemical cost inflation that is squeezing India's personal care and FMCG sector, with raw material costs rising 20–30% and input cost inflation expected at 8–10%. Major manufacturers including Hindustan Unilever have announced price increases of 2–5%, while the world's largest condom maker Karex flagged potential price hikes of up to 30%, and companies are delaying new product launches to protect margins. The disruptions are expected to persist over the next eight quarters, forcing brands to recalibrate supply chains through inventory buffering, supplier diversification, and localisation strategies.Fox NewsSafe sex is about to get more expensive, world’s largest condom maker warnsKarex, the world's largest condom manufacturer, warned it may raise prices by up to 30% as the Middle East conflict strains global supply chains and slows shipping through the Strait of Hormuz. The company, which produces over 5 billion condoms annually and exports to more than 130 countries, is facing soaring costs for key materials including silicone oil (up roughly 30%) and aluminum packaging (at a four-year high), while shipments to the U.S. and Europe face delays of up to two months. The disruptions are raising concerns about supplies to vulnerable populations through UN aid programs, with broader implications for the cost of basic health products.The IndependentThe Latest: Iran proposes to reopen Strait of Hormuz without nuclear agreementIran offered to end its chokehold on the Strait of Hormuz without addressing its nuclear program, officials said Monday, proposing that the United States first lift its blockade of Iranian ports before new negotiations can take place. The proposal, passed to the U.S. through Pakistan-led mediation, appears unlikely to receive backing from President Trump, who has insisted that ending Iran's atomic program must be part of any comprehensive ceasefire deal. The Strait closure has triggered cascading economic effects including rising oil prices, flight cancellations by Transavia France, China's opposition to U.S. sanctions on a Dalian refinery, and a 30% price increase by the world's largest condom manufacturer Karex.The Times of IndiaCondom Prices Surge 30% Amid Iran War Supply Chain Disruptions | Business - The Times of IndiaMalaysia's Karex Bhd, the world's largest condom manufacturer producing over 5 billion condoms annually (one-fifth of global supply), has announced price increases of 20 to 30 percent as the Iran war disrupts naphtha supplies and drives up raw material costs, with some inputs rising by up to 100 percent. Asian naphtha refining margins have surged from $108 per tonne to over $400 per tonne since late February, while shipping delays to Europe and the United States have doubled to nearly two months. The shortage is part of a broader crisis affecting developing countries like Kenya, which faces a 71.9 percent condom funding gap threatening HIV prevention efforts.The GuardianCheap spirits, pricey condoms: how war in the Middle East is shifting the way Australians spendRising petrol prices linked to the Middle East conflict have triggered significant changes in Australian consumer spending habits, with households cutting back on discretionary purchases amid high living costs. Australian consumers are trading down to cheaper spirits and lower alcohol content, bypassing discretionary healthcare procedures, and reducing furniture and bedding purchases, while companies like Cochlear report weakened demand causing its market value to drop over 40%. The economic impact is spreading through supply chains, with Malaysia's Karex planning condom price increases of up to 30% and Australian building suppliers announcing similar price rises, while more consumers turn to buy-now-pay-later services for essential items.The Indian ExpressWar hits bedrooms: Condom prices set to jump 30%, says KarexKarex, the world's largest condom manufacturer based in Malaysia, has announced plans to raise product prices by up to 30% due to raw material shortages and supply chain disruptions caused by the ongoing Iran war. The company, which produces approximately five billion condoms annually, stated that some raw material prices have surged by 100%, while global shipping disruptions and higher freight rates have compounded the pressure. CEO Goh Miah Kiat described the price revision as unavoidable given the escalating input costs.